Home  >  Products  >  KHDRBS3 (KH domain containing, RNA binding, signal transduction associated 3) Blocking Peptide (100ug)
KHDRBS3 (KH domain containing, RNA binding, signal transduction associated 3) Blocking Peptide (100ug)

KHDRBS3 (KH domain containing, RNA binding, signal transduction associated 3) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KHDRBS3 antibody (Catalogue #: ARP40663_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40663
Size: 100 ug
Weight: 38kDa
Gene: 10656
Format: Lyophilized powder
Target: As a RNA-binding protein, KHDRBS3 plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. KHDRBS3 may play a role as a negative regulator of cell growth. It inhibits cell proliferation and involved in splice site selection of vascular endothelial growth factor. It induces an increased concentration-dependent incorporation of exon in CD44 pre-mRNA by direct binding to purine-rich exonic enhancer. RNA-binding abilities are down-regulated by tyrosine kinase PTK6. It also involved in post-transcriptional regulation of HIV-1 gene expression.
See Full Product Listings >